Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2010-019260-37Phase 4Completed
Phase 4, randomised, open-label trial of bleomycin in basal cell carcinoma (BCC) (2 arms), sponsored by Cork Cancer Research Centre. Primary endpoint: Primary efficacy comparison. Started Jun 2010; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2010-019260-37.